Sign In

Drew Watson

Biostatistics and Clinical Development

Dr. Drew Watson is a distinguished leader in biostatistics, clinical development, and personalized medicine, boasting a rich experience spanning over 25 years. He played a pivotal role in the creation of Oncotype Dx by Genomic Health and has established numerous clinical diagnostics ventures. Dr. Watson is currently focused on advancing technologies for early cancer detection, specifically targeting breast, prostate, lung, and colon cancers through his work at CellMax Life. Additionally, he is dedicated to enhancing genomic software platforms to guide healthcare providers on optimal treatment strategies and drug advancements through his involvement with CellWorks. Dr. Watson offers his expertise by serving on various scientific advisory boards and consulting for a wide range of entities in the biopharmaceutical, clinical diagnostic, and venture capital sectors, as well as regulatory and reimbursement bodies.

Drew Watson
Add to my network

Location

San Francisco Bay Area